Taipei, Feb. 14 (CNA) A COVID-19 vaccine made in Taiwan by Medigen Vaccine Biologics Corp. has received emergency use authorization (EUA) in Paraguay after the unblinding of a Phase 3 clinical trial conducted in the South American country, the company said in a statement Monday.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
More in CORONAVIRUS
- Court rejects state compensation claim over toddler's COVID-19 deathThe New Taipei District Court has recently upheld its rejection of a request for state compensation from the parents of a 2-year-old boy who died from complications related to ...11/11/2023 09:00 PM
- Updated Novavax COVID vaccine to arrive in Taiwan in December: CDCNovavax's COVID-19 vaccine against the Omicron subvariant XBB.1.5 will likely arrive in Taiwan in December, putting it on track to be the second vaccine offered against more ...11/08/2023 07:54 PM
- Updated Moderna COVID-19 vaccine now available to general public: CDCPeople of all ages in Taiwan can now receive government-funded shots of Moderna's COVID-19 vaccine against the Omicron subvariant XBB.1.5, the Centers for Disease Control (CDC) ...10/11/2023 03:45 PM
Latest
- Cross-Strait
Canadian author launches civil defense e-book for expats in Taiwan
12/03/2023 09:56 PM - Sports
Taiwan beats Korea 4-0 in Asian Baseball Championship opener
12/03/2023 09:23 PM - Politics
Scenes from the campaign trail: A busy Sunday for main political parties
12/03/2023 09:15 PM - Sports
Taiwan wins 2 golds at tug of war invitation tournament
12/03/2023 09:07 PM - Society
Weather front to bring rain Monday; snow possible in high areas
12/03/2023 08:52 PM